publication venue for
- Correction: Valenti et al. The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas. Cancers 2019, 11, 1347.. 17:1089. 2025
- Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.. 17:522. 2025
- A Prognostic Symptom Model Incorporating Patient-Reported Symptoms for Transplant-Ineligible Patients with Multiple Myeloma.. 17:489. 2025
- A Prospective Monocentric Study of Invasive Breast Carcinoma Diagnosed at 80 Years and Older: Survival Outcomes and Peculiar Challenges.. 16:4142. 2024
- Multiomics-Based Outcome Prediction in Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR).. 16:3425. 2024
- Drug Interactions between Androgen Receptor Axis-Targeted Therapies and Antithrombotic Therapies in Prostate Cancer: Delphi Consensus.. 16:3336. 2024
- Stereotactic Body Radiotherapy for Renal Cell Carcinoma-A Review of Use in the Primary, Cytoreductive and Oligometastatic Settings.. 16:3334. 2024
- The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.. 16:3182. 2024
- Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications.. 16:2878. 2024
- Resistance Training in Women Diagnosed with Breast Cancer: A Pilot Single Arm Pre-Post Intervention.. 16:2829. 2024
- Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities. 16:2116-2116. 2024
- Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors. 15:4818-4818. 2023
- Exploiting Long Non-Coding RNAs and Circular RNAs as Pharmacological Targets in Triple-Negative Breast Cancer Treatment. 15:4181-4181. 2023
- The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma. 15:3672-3672. 2023
- Taxifolin Inhibits Breast Cancer Growth by Facilitating CD8+ T Cell Infiltration and Inducing a Novel Set of Genes including Potential Tumor Suppressor Genes in 1q21.3. 15:3203-3203. 2023
- Impact of a Training Program on Oncology Nurses’ Confidence in the Provision of Self-Management Support and 5As Behavioral Counseling Skills. 15:1811-1811. 2023
- Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells. 15:1295-1295. 2023
- Recent Advances in Optimizing Radiation Therapy Decisions in Early Invasive Breast Cancer. 15:1260-1260. 2023
- Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer. 15:571-571. 2023
- Practical Implications of KRAS Mutation Status and Sidedness of Primary Tumour in Patients with Colorectal Cancer and Synchronous Liver Metastases: A Subset Analysis of the CoSMIC Study. 14:4833-4833. 2022
- Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status. 14:3947-3947. 2022
- Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment. 14:3664-3664. 2022
- Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. 14:3500-3500. 2022
- Yoda1 Enhanced Low-Magnitude High-Frequency Vibration on Osteocytes in Regulation of MDA-MB-231 Breast Cancer Cell Migration. 14:3395-3395. 2022
- Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels. 14:2805-2805. 2022
- How Do the Outcomes of Radiation-Associated Pelvic and Sacral Bone Sarcomas Compare to Primary Osteosarcomas following Surgical Resection?. 14:2179-2179. 2022
- Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises. 14:113-113. 2021
- Insights of RKIP-Derived Suppression of Prostate Cancer. 13:6388-6388. 2021
- Using a Prime-Boost Vaccination Strategy That Proved Effective for High Resolution Epitope Mapping to Characterize the Elusive Immunogenicity of Survivin. 13:6270-6270. 2021
- Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer. 13:5590-5590. 2021
- The Burden of Late Effects and Related Risk Factors in Adolescent and Young Adult Cancer Survivors: A Scoping Review. 13:4870-4870. 2021
- The Psychoneuroimmunology of Stress Regulation in Pediatric Cancer Patients. 13:4684-4684. 2021
- Prognostic and Therapeutic Potential of the OIP5 Network in Papillary Renal Cell Carcinoma. 13:4483-4483. 2021
- Normalizing Tumor Vasculature to Reduce Hypoxia, Enhance Perfusion, and Optimize Therapy Uptake. 13:4444-4444. 2021
- Advances in Immunotherapy for Adult Glioblastoma. 13:3400-3400. 2021
- From Pathways to Practice: Impact of Implementing Mobilization Recommendations in Head and Neck Cancer Surgery with Free Flap Reconstruction. 13:2890-2890. 2021
- Impact of Early Mobilization on Recovery after Major Head and Neck Surgery with Free Flap Reconstruction. 13:2852-2852. 2021
- Prognostic Association between Common Laboratory Tests and Overall Survival in Elderly Men with De Novo Metastatic Castration Sensitive Prostate Cancer: A Population-Based Study in Canada. 13:2844-2844. 2021
- Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy. 13:806-806. 2021
- Effective Prediction of Prostate Cancer Recurrence through the IQGAP1 Network. 13:430-430. 2021
- Decision-making in Surgery or Active Surveillance for Low Risk Papillary Thyroid Cancer During the COVID-19 Pandemic. 13:371-371. 2021
- Construction of a Novel Multigene Panel Potently Predicting Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma. 12:3471-3471. 2020
- RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status. 12:3178-3178. 2020
- Is There a Causal Relationship between Childhood Obesity and Acute Lymphoblastic Leukemia? A Review. 12:3082-3082. 2020
- Loss of Two-Pore Channel 2 (TPC2) Expression Increases the Metastatic Traits of Melanoma Cells by a Mechanism Involving the Hippo Signalling Pathway and Store-Operated Calcium Entry. 12:2391-2391. 2020
- Systematic Review of Patient-Reported Outcomes following Surgical Treatment of Lymphedema. 12:565-565. 2020
- Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis. 11:1723-1723. 2019
- The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas. 11:1347-1347. 2019
- Relevance of Non-Targeted Effects for Radiotherapy and Diagnostic Radiology; A Historical and Conceptual Analysis of Key Players. 11:1236-1236. 2019
- The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer. 11:1028-1028. 2019
- The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis. 11:434-434. 2019
- YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting. 10:137-137. 2018
- Alcohol Misuse Link to POEMS Syndrome in a Patient. 9:129-129. 2017
- The Role of Radiation Induced Injury on Lung Cancer. 9:89-89. 2017
- Oncogenic MicroRNAs: Key Players in Malignant Transformation. 7:2466-2485. 2015
- Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer. 7:2290-2308. 2015
- An Evidence-Based Approach to the Use of Predictive Biomarkers in the Treatment of Non- Small Cell Lung Cancer (NSCLC). 3:3506-3524. 2011